---
category: news
title: "Bio­Marin taps AI up­start Deep Ge­nomics for dis­cov­ery pact; Prax­is says it has a path to lift­ing clin­i­cal hold"
excerpt: "Years after double FDA/EMA rejections left BioMarin’s oligonucleotide for Duchenne muscular dystrophy languishing on the shelf, the company is going back to the drawing board for new oligonucleotide drug candidates — with a healthy dose of artificial intelligence."
publishedDateTime: 2020-11-17T15:30:00Z
originalUrl: "https://endpts.com/biomarin-taps-ai-upstart-deep-genomics-for-discovery-pact-praxis-says-it-has-a-path-to-lifting-clinical-hold/"
webUrl: "https://endpts.com/biomarin-taps-ai-upstart-deep-genomics-for-discovery-pact-praxis-says-it-has-a-path-to-lifting-clinical-hold/"
type: article
quality: 13
heat: 13
published: false

provider:
  name: ENDPOINTS NEWS
  domain: endpts.com

topics:
  - AI

images:
  - url: "https://endpts.com/wp-content/uploads/2020/10/News_briefing_FE.jpg"
    width: 2048
    height: 1024
    isCached: true

secured: "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;8zzRpfQsJ5Ll+V6GnuKzRA=="
---

